5 Stocks Entering the Buy Zone

📊 5 S&P 500 Stocks Worth Considering for a Buy Entry

The U.S. stock market remains near yearly highs, but the earnings season is adding volatility and forcing investors to be more selective. It’s not enough to simply hold positions — the key is to find companies demonstrating real profit growth and steady demand for their products. Below are five names worth watching in November.

Interactive Brokers (IBKR)

One of the largest online brokers in the world is showing solid performance amid growing retail investor activity.

• Profit rose by 30%, and revenue by 21%.
• The company is actively expanding its liquidity management and client deposit services, allowing it to boost income even under high Fed rates.
• The stock trades around $70 — a level seen as an attractive entry zone.

Plan: optimal buy range — $68–71, target zone — $76–78.
Risks are moderate; the growth potential is supported by stable cash flows and low debt levels.

MongoDB (MDB)

The company remains a key player in data infrastructure for artificial intelligence.

• The share price broke above $345 — a technical signal of continued growth.
• Since August, the stock has gained about 60%, driven by demand for cloud solutions and AI integration in corporate systems.
• MongoDB is becoming the infrastructure standard for startups and large enterprises working with big data.

Plan: hold positions; target zone — $390–400.
If the price breaks above $400, a new growth impulse is possible.

Eli Lilly (LLY)

The pharmaceutical giant continues to post phenomenal results, becoming the main beneficiary of the anti-obesity and diabetes drug trend.

• Profit surged 495%, and revenue increased 54%.
• The main driver is its blockbuster drugs Mounjaro and Zepbound, with global demand continuing to rise.
• The company is actively investing in new clinical trials and expanding production capacity.

Plan: buy range — $860–870, target zone — $950–1000.
A strong foundation and steady demand make Eli Lilly one of the most reliable assets in the sector.

Nu Holdings (NU)

The Latin American fintech leader continues to impress with its client base and profitability growth.

• The bank serves over 100 million customers across Brazil, Mexico, and Colombia.
• The market awaits the Q3 report on November 12 — double-digit revenue growth is expected.
• A breakout above $16.5 would open the way to new highs.

Plan: current levels remain attractive for accumulation; target — $18–19.
This stock fits well into a long-term portfolio focused on emerging markets.

JPMorgan Chase (JPM)

The financial giant maintains its dominance among U.S. banks.

• The latest report showed profit up 16% and revenue up 9%.
• JPMorgan continues to adapt to high-rate conditions, expanding its net interest margin and increasing market share.
  
• The bank is also heavily investing in digital infrastructure and risk management technologies.

Plan: buy range — $310–318, target — $335.
This stock suits investors focused on stability and dividends.

💡 Conclusion

Despite high index levels, the market is becoming increasingly selective. The leaders are companies that can deliver real profit growth and sustained demand in a complex macroeconomic environment.

The current investor focus lies in three areas:

1. Technology and AI infrastructure (MongoDB),
2. Pharmaceuticals and biotech (Eli Lilly),
3. Next-generation finance (Nu Holdings and Interactive Brokers).

Even near record highs, there are still attractive entry points — but strategy must remain disciplined, as the high-rate environment demands caution and precision.